FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Portland International Airport carpet reaches celebrity status|
|Oregon locals and visitors lined up inside Portland International Airport last week to snap photos with a 30-year-old carpet that has reached celebrity status.|
|Social media, smartphone apps among online tools used to fuel anonymous threats in schools|
|Threats against schools don't just come written on bathroom walls these days.|
|Western governors tout sage grouse conservation efforts to avoid endangered species listing|
|A group of Western-state governors has released a report on voluntary efforts in 11 states to conserve the habitat of sage grouse as part of an effort to avoid a federal listing of the bird under the Endangered Species Act.|
|Mother of Getty heir's girlfriend says he had brain aneurysm|
|The mother of oil heir Andrew Getty's on-again, off-again girlfriend said Wednesday that he had recently been diagnosed with a brain aneurysm as it emerged that Getty had sought a restraining order against her daughter weeks before his death.|
|Arkansas, Indiana lawmakers race to update religious objection bills criticized as anti-gay|
|Lawmakers in Arkansas and Indiana are scrambling to revise controversial religious objection measures as Republican governors in both states try to quell a growing backlash from businesses and other critics who have called the proposals anti-gay.|
|The latest developments on widely criticized religious objections laws in Indiana, Arkansas|
|A day after Arkansas lawmakers defied criticism to pass a religious objections bill, the governor of Arkansas held off on signing the measure, saying it needed changes before he could make the proposal into law.|
|Hawaii art museum returns seven artifacts found to be smuggled from India|
|An international investigation into antiquities looted from India and smuggled into the United States has taken authorities to the Honolulu Museum of Art.|
|AP Poll: 5 things to know about what Americans think about gay rights and religious liberty|
|Most Americans support allowing businesses to refuse wedding-related services to same-sex couples on religious grounds, according to an Associated Press-GfK poll conducted earlier this year.|
|US Navy hopes rule changes will free Japanese to operate more globally with more partners|
|Even as Japan remains divided over proposed changes in the role it should play in regional security issues, senior U.S. and Japanese military officers say they hope the Japanese navy may soon be freed up to play a more active role in the Pacific and beyond, plying some of the world's most hotly contested waters.|
|Tennessee prosecutor fired after reports of female sterilization in plea deals|
|A Nashville prosecutor has been fired after reports surfaced that he made sterilization of women part of plea negotiations in some cases.|